MEPHAMESON sol inj 50 mg/3ml 25 amp 3 ml
7680318900983
CH-31890
H02AB02
07.07.26
1 / 3
google
Details
- Product number
- 3189002
- CPT
- -
- Packaging group
- 25 x 3 mL
- Unit
- Ampulle(n)
- Composition
- dexamethasoni natrii phosphas 50.00 mg corresp. dexamethasonum 38 mg, dinatrii edetas, propylenglycolum 450.00 mg, natrii hydroxidum ad pH, aqua ad iniectabile q.s. ad solutionem pro 3 ml corresp. natrium max. 4.50 mg.
Articles (1)
Mephameson 50 mg/3 ml, Injektionslösung
Injektionslösung
25 x 3 mL
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | WIZUS |
|
(N/A)
|
38.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
450.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 358.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2020
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 31890
- Drug name
- Mephameson, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- H02AB02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 15/11/1965
- Authorization expiration date
- 31/12/9999
- IT number
- 07.07.26
- Domain
- Human medicine
Packaging details
- Description (FR)
- MEPHAMESON sol inj 50 mg/3ml 25 amp 3 ml
- Description (DE)
- MEPHAMESON Inj Lös 50 mg/3ml 25 Amp 3 ml
- Market launch
- 15/11/1965
- Narcotic (BTM)
- No